BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9919060)

  • 1. Ovarian cancer. It whispers ... so listen!
    Gill MA
    Adv Nurse Pract; 1998 Nov; 6(11):48, 50, 52-4. PubMed ID: 9919060
    [No Abstract]   [Full Text] [Related]  

  • 2. 'It whispers, so listen'.
    Lehman ML
    RN; 2007 Oct; 70(10):28-32; quiz 33. PubMed ID: 17987818
    [No Abstract]   [Full Text] [Related]  

  • 3. Managing ovarian cancer--a GP guide.
    Brinkmann D; Jacobs I
    Practitioner; 2001 Apr; 245(1621):276-9, 281-2, 286. PubMed ID: 11332002
    [No Abstract]   [Full Text] [Related]  

  • 4. [Screening for ovarian cancer].
    Bjørge T; Dørum A; Tropé CG
    Tidsskr Nor Laegeforen; 2000 May; 120(12):1444-8. PubMed ID: 10851943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophospholipids are potential biomarkers of ovarian cancer.
    Sutphen R; Xu Y; Wilbanks GD; Fiorica J; Grendys EC; LaPolla JP; Arango H; Hoffman MS; Martino M; Wakeley K; Griffin D; Blanco RW; Cantor AB; Xiao YJ; Krischer JP
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1185-91. PubMed ID: 15247129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumor marker in ovarian cancer].
    Komai K; Nishida T
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):481-6. PubMed ID: 11915744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. StatBite: Ovarian cancer: risk of recurrence by stage of diagnosis.
    J Natl Cancer Inst; 2009 Sep; 101(18):1234. PubMed ID: 19738164
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lysophospholipids].
    Nakamura K; Yatomi Y
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():809-11. PubMed ID: 16149647
    [No Abstract]   [Full Text] [Related]  

  • 9. CASA and Ca 125 in diagnosis and follow-up of advanced ovarian cancer.
    Oehler MK; Sütterlin M; Caffier H
    Anticancer Res; 1999; 19(4A):2513-8. PubMed ID: 10470185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of biological markers in the differential diagnosis in the staging of ovarian neoplasms].
    Nigro G; Midiri G; Amanti C; Galassi G; Custo GM
    Minerva Ginecol; 1988 Apr; 40(4):227-9. PubMed ID: 3173771
    [No Abstract]   [Full Text] [Related]  

  • 11. A new model of ovarian carcinogenesis may influence early detection strategies.
    Burger RA
    Am J Obstet Gynecol; 2008 Apr; 198(4):349-50. PubMed ID: 18395029
    [No Abstract]   [Full Text] [Related]  

  • 12. Listen for the "whispering disease". Learn the subtle signs and symptoms of ovarian cancer.
    Martin VR
    Nurs Manage; 2000 Apr; 31(4):30-1. PubMed ID: 15127636
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combined use of tumor markers and MRI tomography in differential diagnosis of ovarian neoplasms].
    Pavlov SB; Akulina EA; Pavlova GB
    Klin Med (Mosk); 1999; 77(4):49-51. PubMed ID: 10356919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors.
    Begum FD; Høgdall E; Kjaer SK; Blaakaer J; Christensen IJ; Christensen L; Høgdall C
    Gynecol Oncol; 2009 May; 113(2):221-7. PubMed ID: 19261323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic relevance of soluble interleukin-2 receptors in patients with ovarian tumors.
    Gebauer G; Rieger M; Jäger W; Lang N
    Anticancer Res; 1999; 19(4A):2509-11. PubMed ID: 10470184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The early diagnosis and treatment of ovarian cancer. A paper awarded the Prize of the Academia. The year 1990].
    Escudero Fernández M
    An R Acad Nac Med (Madr); 1991; 108(1):19-82. PubMed ID: 1767880
    [No Abstract]   [Full Text] [Related]  

  • 17. Oncology today: ovarian cancer.
    Tiedemann D
    RN; 2000 Oct; 63(10):36-41; quiz 42. PubMed ID: 11062665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases.
    Shen Z; Wu M; Elson P; Kennedy AW; Belinson J; Casey G; Xu Y
    Gynecol Oncol; 2001 Oct; 83(1):25-30. PubMed ID: 11585410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian cancer: Listen for the disease that whispers.
    Blewitt K
    Nursing; 2010 Nov; 40(11):24-31; quiz 31-2. PubMed ID: 20921913
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of ovarian cancer].
    Cianti C
    Clin Ter; 2002; 153(2):135-44. PubMed ID: 12078339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.